Candid Therapeutics, Inc.
About Candid Therapeutics, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Capital Raise T: - FT: Capital Raise |
A: 370000000 MR: - FA: $370 million FAN: 370000000 |
D: 2024-09-09 FD: 2024-09-09 |
19 investors |
Growth Metrics
Team & Leadership
Ken Song
President & CEO
Tim Lu
Chief Medical Officer & Chief Scientific Officer
Arvind Kush
Chief Financial Officer & Chief Business Officer
Bernie Huyghe
Chief Technology Officer
David Luo
Senior Vice President, Clinical Operations
Jeff Woodley
General Counsel
Recent News
Candid Therapeutics, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- candidrx.com
- Industries
- Biotechnology/Healthcare
- Company Size
- ~260 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro